We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01852292
Recruitment Status : Completed
First Posted : May 13, 2013
Last Update Posted : January 9, 2018
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )